SCHEMBL1924409

SCHEMBL1924409

CCCC(=O)C(OC(C)CC)(OC(C)CC)C(=O)[O-].CCCC(=O)C(OC(C)CC)(OC(C)CC)C(=O)[O-].CCCC(=O)C(OC(C)CC)(OC(C)CC)C(=O)[O-].[Al+3]

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.34
HDAC3 O15379 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
HDAC8 Q9BY41 2/20 0.34
CES2 O00748 1/20 0.32
CES1 P23141 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207036 0.86 FFAR3 (0.37) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL104903 0.73 FFAR3 (0.38) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL29761915 0.71
SCHEMBL105786 0.70 CA1 (0.36) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL105851 0.69 FFAR3 (0.38) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL104420 0.69 FFAR3 (0.38) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL2384263 0.69 FFAR3 (0.38) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL8631802 0.68 HDAC3 (0.41) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL992243 0.67 FFAR3 (0.36) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL106135 0.67 CA1 (0.36) FFAR3HDAC3HDAC1HDAC2HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112654661-A Curable silicone composition and light diffusing material formed therefrom 美国陶氏有机硅公司 2021-04-13 CN disclosed
EP-1504051-B1 ORGANO-FUNCTIONAL POLYSILOXANES SIGMAKALON SERVICES B V (NL) 2011-06-08 EP disclosed
EP-1608694-B1 PROCESS FOR THE PREPARATION OF HIGH SOLIDS URETHANE ALKYDS PPG BV (NL) 2008-11-05 EP disclosed
US-20060252953-A1 Process for the production of silyl carboxylate monomers SIGMA COATINGS B.V. (NL) 2006-11-09 US disclosed
US-7118621-B2 Organo-functional polysiloxanes SIGMAKALON SERVICES B.V. (NL) 2006-10-10 US disclosed
EP-0990660-B1 PROCESS FOR PREPARING CYCLIC OLIGOSILOXANES KANEKA CORP (JP) 2006-04-26 EP disclosed
EP-1608694-A1 PROCESS FOR THE PREPARATION OF HIGH SOLIDS URETHANE ALKYDS SigmaKalon B.V. (NL) 2005-12-28 EP disclosed
US-20050222446-A1 Process for the production of hydrocarbyl silyl carboxylate compounds SIGMA COATINGS B.V. (NL) 2005-10-06 US disclosed
US-20050202257-A1 Organo-functional polysiloxanes SIGMAKALON SERVICES B.V. (NL) 2005-09-15 US disclosed
EP-1572701-A1 PROCESS FOR THE PRODUCTION OF HYDROCARBYL SILYL CARBOXYLATE COMPOUNDS SIGMA COATINGS B.V. (NL) 2005-09-14 EP disclosed
EP-1501884-A1 AMINO-FUNCTIONAL POLYSILOXANES AND THEIR USE IN COATINGS SigmaKalon Services B.V. (NL) 2005-02-02 EP disclosed
WO-2004101639-A1 PROCESS FOR THE PREPARATION OF HIGH SOLIDS URETHANE ALKYDS SIGMAKALON B.V. (NL) 2004-11-25 WO disclosed
WO-2004056837-A1 PROCESS FOR THE PRODUCTION OF HYDROCARBYL SILYL CARBOXYLATE COMPOUNDS SIGMA COATINGS B.V. (NL) 2004-07-08 WO disclosed
EP-1431301-A1 Process for the production of silyl carboxylate monomers SIGMA COATINGS B.V. (NL) 2004-06-23 EP disclosed
WO-2003093352-A1 AMINO-FUNCTIONAL POLYSILOXANES AND THEIR USE IN COATINGS SIGMAKALON SERVICES B.V. (NL) 2003-11-13 WO disclosed
WO-2003093350-A1 ORGANO-FUNCTIONAL POLYSILOXANES SIGMAKALON SERVICES B.V. (NL) 2003-11-13 WO disclosed
EP-1361245-A1 Amino-functional polysiloxanes SigmaKalon Group B.V. (NL) 2003-11-12 EP disclosed
EP-1359182-A1 Organo-functional polysiloxanes SigmaKalon Group B.V. (NL) 2003-11-05 EP disclosed
US-6262289-B1 HEATING IN PRESENCE OF METAL ALKOXIDE KANEKA CORPORATION (JP) 2001-07-17 US disclosed
EP-0990660-A1 PROCESS FOR PREPARING CYCLIC OLIGOSILOXANES Kaneka Corporation (JP) 2000-04-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252953-A1 Process for the production of silyl carboxylate monomers ACSL1, SUCLA2, MSMO1 FFAR3 2092/4885HDAC3 1606/4885HDAC1 668/4885
US-20050222446-A1 Process for the production of hydrocarbyl silyl carboxylate compounds FTO, SUCLG2, ALKBH3 FFAR3 3096/4885HDAC3 1760/4885HDAC1 1707/4885
US-20050202257-A1 Organo-functional polysiloxanes H1-3, HAO2, LPO FFAR3 489/4885HDAC3 202/4885HDAC1 166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.